• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Scandidos

0.85 SEK+6.25 %10/7 17:29
Less than 1K followers

SDOS

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+6.25 %
-1.73 %
-13.27 %
-28.57 %
-28.57 %
-39.29 %
-68.05 %
-77.86 %
-93.85 %

Scandidos operates in the medical technology sector. The company offers products and systems for quality assurance of advanced radiation therapy for cancer. The systems analyze the radiation dose before and during ongoing radiation treatment. The company was founded in 2002 and the first product was launched in 2006. Since its inception, Scandidos has delivered products to radiation therapy clinics on a global level. The head office is located in Uppsala.

Read more
Market cap
60.57M SEK
Turnover
206.69K SEK
Revenue
54.22M
EBIT %
-5.51 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17/9
2026

Interim report Q1'27

21/10
2026

General meeting '26

15/12
2026

Interim report Q2'27

Regulatory press release2026-07-10 17:00

Företrädesemissionen i ScandiDos blev fulltecknad

Scandidos
Regulatory press release2026-06-22 23:00

Företrädesemissionen i ScandiDos inleds

Scandidos
Regulatory press release2026-06-16 14:42

KOMMUNIKÉ FRÅN BOLAGSSTÄMMA I SCANDIDOS AB (PUBL)

Scandidos

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-06-16 08:00

ScandiDos AB - Bokslutskommuniké 1 maj 2025 - 30 apr 2026

Scandidos
Regulatory press release2026-06-02 14:15

Kallelse till extra bolagsstämma i ScandiDos AB (publ)

Scandidos
Regulatory press release2026-06-02 08:30

Styrelsen i ScandiDos AB föreslår en företrädesemission om 12,8 MSEK för lansering av Delta4 SRS Pro

Scandidos
Press release2026-05-15 08:00

ScandiDos presenterar Delta4 SRS Pro på ESTRO 2026: Sätter en ny standard för stereotaktisk kvalitetssäkring.

Scandidos
Press release2026-05-15 08:00

ScandiDos Unveils Delta4 SRS Pro at ESTRO 2026: Setting a New Standard for Stereotactic QA

Scandidos
Regulatory press release2026-05-06 14:00

Anders Murman utses till tillförordnad VD för ScandiDos

Scandidos
Regulatory press release2026-05-06 14:00

Anders Murman appointed Acting CEO of ScandiDos

Scandidos
Regulatory press release2026-03-18 08:00

ScandiDos AB - Delårsrapport 1 maj 2025 – 31 jan 2026

Scandidos
Regulatory press release2025-12-16 08:00

ScandiDos AB - Delårsrapport 1 maj 2025 – 31 okt 2025

Scandidos
Regulatory press release2025-11-28 11:00

Uttalande från styrelsen i ScandiDos AB (publ) med anledning av budpliktserbjudandet från Spore Invest AB

Scandidos
Press release2025-10-27 19:15

Scandidos informerar om att Spore Invest AB har passerat gränsen för budplikt

Scandidos
Regulatory press release2025-10-23 17:45

KOMMUNIKÉ FRÅN ÅRSSTÄMMA I SCANDIDOS AB (PUBL)

Scandidos
Regulatory press release2025-09-24 08:30

ScandiDos AB Årsredovisning 2024/2025

Scandidos
Regulatory press release2025-09-24 08:00

KALLELSE TILL ÅRSSTÄMMA I SCANDIDOS AB (PUBL)

Scandidos
Regulatory press release2025-09-18 08:00

ScandiDos AB - Delårsrapport 1 maj 2025 – 31 jul 2025

Scandidos
Regulatory press release2025-08-29 10:30

ScandiDos AB byter Certified Adviser till Tapper Partners AB

Scandidos
Regulatory press release2025-06-18 08:00

ScandiDos AB - Bokslutskommuniké 1 maj 2024 – 30 apr 2025

Scandidos